Aug 10, 2018 FDA OKs Patisiran (Onpattro) for Polyneuropathy in hAATR FDA OKs Patisiran (Onpattro) for Polyneuropathy in hAATRThe results were presented in April at the American Academy of Neurology 2018 Annual Meeting. As reported by Medscape Medical News, patisiran ... read morePublished on 2018-08-10